These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 2323040)

  • 1. Determination of carbamylated hemoglobin by high-performance liquid chromatography.
    Kwan JT; Carr EC; Bending MR; Barron JL
    Clin Chem; 1990 Apr; 36(4):607-10. PubMed ID: 2323040
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Temporal changes and reversibility of carbamylated hemoglobin in renal failure.
    Han JS; Kim YS; Chin HJ; Jeon US; Ahn C; Kim S; Lee JS; Jang IJ; Shin SG
    Am J Kidney Dis; 1997 Jul; 30(1):36-40. PubMed ID: 9214399
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Use of carbamylated hemoglobin concentration to differentiate acute from chronic renal failure in dogs.
    Vaden SL; Gookin J; Trogdon M; Langston CE; Levine J; Cowgill LD
    Am J Vet Res; 1997 Nov; 58(11):1193-6. PubMed ID: 9361876
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Carbamylated hemoglobin in hemodialysis patients.
    Tarif N; Shaykh M; Stim J; Arruda JA; Dunea G
    Am J Kidney Dis; 1997 Sep; 30(3):361-5. PubMed ID: 9292564
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Factors determining hemoglobin carbamylation in renal failure.
    Stim J; Shaykh M; Anwar F; Ansari A; Arruda JA; Dunea G
    Kidney Int; 1995 Nov; 48(5):1605-10. PubMed ID: 8544421
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Kinetics of carbamylated haemoglobin in acute renal failure.
    Wynckel A; Randoux C; Millart H; Desroches C; Gillery P; Canivet E; Chanard J
    Nephrol Dial Transplant; 2000 Aug; 15(8):1183-8. PubMed ID: 10910442
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Carbamylated hemoglobin and carbamylated plasma protein in hemodialyzed patients.
    Balion CM; Draisey TF; Thibert RJ
    Kidney Int; 1998 Feb; 53(2):488-95. PubMed ID: 9461111
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Carbamylated haemoglobin, urea kinetic modelling and adequacy of dialysis in haemodialysis patients.
    Kwan JT; Carr EC; Neal AD; Burdon J; Raftery MJ; Marsh FP; Barron JL; Bending MR
    Nephrol Dial Transplant; 1991; 6(1):38-43. PubMed ID: 2057114
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The role of carbamylated hemoglobin in identifying acute and chronic renal failure.
    Tasanarong A; Seublinvong T; Eiam-Ong S
    J Med Assoc Thai; 2002 Apr; 85(4):462-9. PubMed ID: 12118493
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Carbamylated hemoglobin: a potential marker for the adequacy of hemodialysis therapy in end-stage renal failure.
    Davenport A; Jones S; Goel S; Astley JP; Feest TG
    Kidney Int; 1996 Oct; 50(4):1344-51. PubMed ID: 8887297
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Carbamylated haemoglobin in chronic renal failure.
    Smith WG; Holden M; Benton M; Brown CB
    Clin Chim Acta; 1988 Dec; 178(3):297-303. PubMed ID: 3240603
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Enzyme immunoassay of hemoglobin A1c: analytical characteristics and clinical performance for patients with diabetes mellitus, with and without uremia.
    Engbaek F; Christensen SE; Jespersen B
    Clin Chem; 1989 Jan; 35(1):93-7. PubMed ID: 2463121
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Carbamylated Hemoglobin can Differentiate Acute Kidney Injury from Chronic Kidney Disease.
    Naresh Y; Srinivas N; Vinapamula KS; Pullaiah P; Rao PVLNS; Sivakumar V
    Indian J Nephrol; 2018; 28(3):187-190. PubMed ID: 29962667
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Glycosylated hemoglobin in chronic renal insufficiency].
    Grassi R; Macchia M; Dazzi F
    Minerva Med; 1981 Feb; 72(4-5):233-6. PubMed ID: 7207846
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Differentiation of acute from chronic renal impairment by detection of carbamylated haemoglobin.
    Davenport A; Jones SR; Goel S; Astley JP; Hartog M
    Lancet; 1993 Jun; 341(8861):1614-7. PubMed ID: 8099989
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A hemoglobin A1C immunoassay method not affected by carbamylated hemoglobin.
    Rose AM; Tongate C; Valdes R
    Ann Clin Lab Sci; 1995; 25(1):13-9. PubMed ID: 7762964
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Carbamylated haemoglobin in normal, diabetic and uraemic patients.
    Kwan JT; Carr EC; Barron JL; Bending MR
    Ann Clin Biochem; 1992 Mar; 29 ( Pt 2)():206-9. PubMed ID: 1626926
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Minor haemoglobin fractions in uraemic and in diabetic patients.
    Lantz B; Wajcman H; Beaufils M; Meyrier A; Labie D; Assan R
    Diabete Metab; 1981 Jun; 7(2):109-14. PubMed ID: 6788617
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Carbamylated hemoglobin interference in glycohemoglobin assays.
    Weykamp CW; Miedema K; de Haan T; Doelman CJ
    Clin Chem; 1999 Mar; 45(3):438-40. PubMed ID: 10053058
    [No Abstract]   [Full Text] [Related]  

  • 20. Origin of glycosylated hemoglobin A1 in chronic renal failure.
    De Marchi S; Cecchin E; Camurri C; Quaia P; Raimondi A; Donadon W; Lippi U; Tesio F
    Int J Artif Organs; 1983 Mar; 6(2):77-82. PubMed ID: 6840896
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.